![Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors](https://assets.cureus.com/uploads/figure/file/212710/aa4b7b40b1e611eb90a7718fc86ee1e6-Figure-1_900-revised.png)
Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
![Prospective Characterization of Progressive Supranuclear Palsy in a Multi-Ethnic Asian Cohort | medRxiv Prospective Characterization of Progressive Supranuclear Palsy in a Multi-Ethnic Asian Cohort | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/10/04/2022.10.01.22280553/F1.large.jpg)
Prospective Characterization of Progressive Supranuclear Palsy in a Multi-Ethnic Asian Cohort | medRxiv
![Automated Quantitative MRI Biomarkers in Differentiation of Progressive Supranuclear Palsy and Multiple System Atrophy from Parkinson Disease - MDS Abstracts Automated Quantitative MRI Biomarkers in Differentiation of Progressive Supranuclear Palsy and Multiple System Atrophy from Parkinson Disease - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2019/07/0292_0427_000531_002.png)